Information:
Fel:
ID
13475
Beskrivning
Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
Nyckelord
Versioner (5)
- 2015-03-05 2015-03-05 -
- 2015-03-09 2015-03-09 -
- 2015-04-24 2015-04-24 -
- 2015-12-15 2015-12-15 -
- 2016-02-11 2016-02-11 -
Uppladdad den
11 februari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
End of Study AMLSG 21-13 DRKS00007189 NCT02013648 Akute myeloische Leukämie (AML)
End of Study AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Similar models
End of Study AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
End of Study Date
Item
End of Study Date
date
C2983670 (UMLS CUI-1)
CL Item
regular End of Study (0)
C0205272 (UMLS CUI-1)
CL Item
no CR after Induction (Progressive Disease) (1)
C1335499 (UMLS CUI-1)
CL Item
exzessive extramedullary medical toxicity (2)
C0013221 (UMLS CUI-1)
CL Item
death (3)
C0021430 (UMLS CUI-1)
CL Item
relapse after CR (4)
C0035020 (UMLS CUI-1)
CL Item
Withdrawal of informed consent (5)
C0021430 (UMLS CUI-1)
C1710677 (UMLS CUI-2)
C1710677 (UMLS CUI-2)
CL Item
Protocol deviation (6)
C1705236 (UMLS CUI-1)
CL Item
other (7)
C0205394 (UMLS CUI-1)
Specify if Reason for End of Study = 6 or 7
Item
Specify if Reason for End of Study = 6 or 7
text
C1521902 (UMLS CUI [1])
Induction therapy I administered
Item
Induction therapy I administered
boolean
C3179010 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205447 (UMLS CUI [1,3])
C0806914 (UMLS CUI [1,2])
C0205447 (UMLS CUI [1,3])
Induction therapy II administered
Item
Induction therapy II administered
boolean
C3179010 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205448 (UMLS CUI [1,3])
C0806914 (UMLS CUI [1,2])
C0205448 (UMLS CUI [1,3])
Consolidation therapy I administered
Item
Consolidation therapy I administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205447 (UMLS CUI [1,3])
C0806914 (UMLS CUI [1,2])
C0205447 (UMLS CUI [1,3])
Consolidation therapy II administered
Item
Consolidation therapy II administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205448 (UMLS CUI [1,3])
C0806914 (UMLS CUI [1,2])
C0205448 (UMLS CUI [1,3])
Consolidation therapy III administered
Item
Consolidation therapy III administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205449 (UMLS CUI [1,3])
C0806914 (UMLS CUI [1,2])
C0205449 (UMLS CUI [1,3])
Consolidation therapy IV administered
Item
Consolidation therapy IV administered
boolean
C3179017 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0205450 (UMLS CUI [1,3])
C0806914 (UMLS CUI [1,2])
C0205450 (UMLS CUI [1,3])
Maintenance therapy administered
Item
Maintenance therapy administered
boolean
C0481504 (UMLS CUI [1,1])
C0806914 (UMLS CUI [1,2])
C0806914 (UMLS CUI [1,2])
Date
Item
Date
date
C0011008 (UMLS CUI-1)
Name of Investigator
Item
Name of Investigator
text
C2826892 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)